tiprankstipranks
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Hong Kong Market

Shanghai Junshi Biosciences Co., Ltd. Class H (1877) Financial Statements

Compare
3 Followers

Shanghai Junshi Biosciences Co., Ltd. Class H Financial Overview

Shanghai Junshi Biosciences Co., Ltd. Class H's market cap is currently HK$25.87B. The company's EPS TTM is HK$-1.982; its P/E ratio is ―; Shanghai Junshi Biosciences Co., Ltd. Class H is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 1.50B¥ 1.45B¥ 4.02B¥ 1.59B¥ 775.09M
Gross Profit¥ 835.26M¥ 927.21M¥ 2.77B¥ 1.22B¥ 684.40M
Operating Income¥ -2.46B¥ -2.67B¥ -685.33M¥ -1.68B¥ -764.44M
EBITDA¥ -2.16B¥ -2.38B¥ -422.77M¥ -1.53B¥ -704.85M
Net Income¥ -2.28B¥ -2.58B¥ -728.18M¥ -1.67B¥ -744.23M
Balance Sheet
Cash & Short-Term Investments¥ 3.78B¥ 6.00B¥ 3.50B¥ 3.39B¥ 1.21B
Total Assets¥ 11.36B¥ 12.58B¥ 11.05B¥ 8.01B¥ 4.42B
Total Debt¥ 1.79B¥ 1.32B¥ 628.20M¥ 850.78M¥ 862.97M
Net Debt¥ -1.99B¥ -4.68B¥ -2.88B¥ -2.53B¥ -351.06M
Total Liabilities¥ 4.02B¥ 2.78B¥ 2.72B¥ 2.17B¥ 1.43B
Stockholders' Equity¥ 7.17B¥ 9.50B¥ 7.96B¥ 5.84B¥ 2.99B
Cash Flow
Free Cash Flow¥ -2.85B¥ -2.17B¥ -1.53B¥ -2.09B¥ -2.05B
Operating Cash Flow¥ -2.01B¥ -1.78B¥ -641.90M¥ -1.50B¥ -1.19B
Investing Cash Flow¥ -892.42M¥ -467.62M¥ -1.88B¥ -697.98M¥ -952.03M
Financing Cash Flow¥ 681.04M¥ 4.64B¥ 2.67B¥ 4.41B¥ 593.58M
Currency in CNY

Shanghai Junshi Biosciences Co., Ltd. Class H Earnings and Revenue History

Shanghai Junshi Biosciences Co., Ltd. Class H Debt to Assets

Shanghai Junshi Biosciences Co., Ltd. Class H Cash Flow

Shanghai Junshi Biosciences Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis